Tag: ivosidenib for MDS

Home / ivosidenib for MDS

Categories

Ivosidenib is approved by FDA for myelodysplastic syndromes

Nov 2023: The Food and Drug Administration (FDA) approved Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) in November 2023 for the treatment of adult patients with relapsed or refractory myelod...
ivosidenib-for-mds

Scan the code